Daniel Janney's Net Worth

$67 Thousand

Who is Daniel Janney?

Daniel Janney does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., ZS Pharma, Inc., SUTRO BIOPHARMA INC, TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., ANESIVA, INC., ATS MEDICAL INC, RENOVIS INC, Allakos Inc., CUTERA INC, DYNAVAX TECHNOLOGIES CORP, NeurogesX Inc, ACELRX PHARMACEUTICALS INC, ICAGEN INC, FLAMEL TECHNOLOGIES SA, INTARCIA THERAPEUTICS, INC, TorreyPines Therapeutics, Inc., OCCAM NETWORKS INC/DE, COTHERIX INC, Krystal Biotech, Inc., Tyra Biosciences, Inc., Carbylan Therapeutics, Inc., Esperion Therapeutics, Inc., AERIE PHARMACEUTICALS INC, VIVEVE MEDICAL, INC., and ELLIE MAE INC.

SEC CIK

Daniel Janney's CIK is 0001198325

Past Insider Trading and Trends

2005 was Daniel Janney's most active year for acquiring shares with 7 total transactions. Daniel Janney's most active month to acquire stocks was the month of April. 2007 was Daniel Janney's most active year for disposing of shares, totalling 12 transactions. Daniel Janney's most active month to dispose stocks was the month of December. 2005 saw Daniel Janney paying a total of $191,500.00 for 112,451 shares, this is the most they've acquired in one year. In 2007 Daniel Janney cashed out on 127,260 shares for a total of $1,718,010.00, their largest year based on trade value.